NI
Nextech Invest Portfolio holdings
AUM
$528M
This Quarter Return
-22.23%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$380M
AUM Growth
–
Cap. Flow
+$380M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
97.96%
Holding
11
New
11
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$89.4M |
| 2 |
Revolution Medicines
RVMD
|
$74.7M |
| 3 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$53.3M |
| 4 |
Tyra Biosciences
TYRA
|
$35.4M |
| 5 |
PMV Pharmaceuticals
PMVP
|
$32M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
| $89.4M | 23.55% | +13,104,424 | New | +$89.4M |
|
|
2
Revolution Medicines
RVMD
$7.1B
| $74.7M | 19.68% | +2,968,214 | New | +$74.7M |
|
|
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $53.3M | 14.04% | +3,008,243 | New | +$53.3M |
|
|
4
Tyra Biosciences
TYRA
$675M
| $35.4M | 9.34% | +2,518,582 | New | +$35.4M |
|
|
5
PMV Pharmaceuticals
PMVP
$74.2M
| $32M | 8.43% | +1,385,807 | New | +$32M |
|
6
Arvinas
ARVN
$568M
| $23.6M | 6.22% | +287,251 | New | +$23.6M |
|
|
KRON
7
DELISTED
Kronos Bio
KRON
| $19.7M | 5.2% | +1,451,537 | New | +$19.7M |
|
8
Cullinan Oncology
CGEM
$445M
| $18.8M | 4.96% | +1,221,145 | New | +$18.8M |
|
9
ARS Pharmaceuticals
SPRY
$1.15B
| $12.7M | 3.35% | +1,910,029 | New | +$12.7M |
|
10
C4 Therapeutics
CCCC
$185M
| $12.1M | 3.19% | +375,857 | New | +$12.1M |
|
|
THRX
11
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $7.75M | 2.04% | +611,310 | New | +$7.75M |
|